| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/03/2015 | US8969291 Methods for decreasing leptin levels or activity for treating inflammation |
| 03/03/2015 | US8969040 Pharmaceutical agent comprising anti-BMP9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia |
| 03/03/2015 | US8969036 Process for obtaining antibodies |
| 03/03/2015 | US8969012 Immunogens for treatment of neoplastic and infectious disease |
| 03/03/2015 | US8968996 Compositions and methods for rapid immunization against dengue virus |
| 03/03/2015 | US8968782 Combination degradable and non-degradable matrices for active agent delivery |
| 03/03/2015 | US8968763 Block biodegradable copolymers for medical devices |
| 03/03/2015 | US8968750 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other C2-domain containing proteins |
| 03/03/2015 | US8968749 Vaccine composition and immunization method |
| 03/03/2015 | US8968748 GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 03/03/2015 | US8968747 Injection paradigm for administration of botulinum toxins |
| 03/03/2015 | US8968746 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
| 03/03/2015 | US8968745 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 03/03/2015 | US8968744 Aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 03/03/2015 | US8968743 Method and compositions for cutaneous immunisation |
| 03/03/2015 | US8968742 Antibody drug conjugates (ADC) that bind to 158P1D7 proteins |
| 03/03/2015 | US8968741 Anti-CD22 antibodies and immunoconjugates and methods of use |
| 03/03/2015 | US8968740 Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 |
| 03/03/2015 | US8968739 Antibody and methods for selective inhibition of T-cell responses |
| 03/03/2015 | US8968738 Methods of treating autoimmune diseases with anti-FcεRI antibodies |
| 03/03/2015 | US8968736 Human antibodies to GFRα3 and methods of use thereof |
| 03/03/2015 | US8968735 Compositions and methods including a recombinant human MAB that promotes CNS remyelination |
| 03/03/2015 | US8968734 Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies |
| 03/03/2015 | US8968733 Functionalized surgical adhesives |
| 03/03/2015 | US8968732 Methods of treating pain using an IL-31 monoclonal antibody |
| 03/03/2015 | US8968731 Treatment of uveitis |
| 03/03/2015 | US8968730 FcγRIIB specific antibodies and methods of use thereof |
| 03/03/2015 | US8968720 Heat shock protein GP96 vaccination and methods of using same |
| 03/03/2015 | US8968719 Live, oral vaccine for protection against Shigella dysenteriae serotype 1 |
| 03/03/2015 | US8968716 In situ-forming hydrogel for tissue adhesives and biomedical use thereof |
| 03/03/2015 | US8968699 Switchable nano-vehicle delivery systems, and methods for making and using them |
| 02/26/2015 | WO2015027163A1 Immuno-oncolytic therapies |
| 02/26/2015 | WO2015026912A1 Porcine circovirus type 2 (pcv2) subunit vaccine |
| 02/26/2015 | WO2015026892A1 Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof |
| 02/26/2015 | WO2015026684A1 Modulation of tumor immunity |
| 02/26/2015 | WO2015026634A1 Treating cancer with a combination of a pd-1 antagonist and dinaciclib |
| 02/26/2015 | WO2015025900A1 Anti-influenza virus-neutralizing antibody |
| 02/26/2015 | WO2015025786A1 HUMAN ANTIBODY κ TYPE LIGHT CHAIN COMPLEX-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME |
| 02/26/2015 | WO2015025068A1 Recombinant vaccine against viral hemorrhagic septicemia virus |
| 02/26/2015 | WO2015024932A1 Fowl adenovirus vaccine |
| 02/26/2015 | WO2015024929A2 Fowl adenovirus vaccine |
| 02/26/2015 | WO2015024673A1 Vaccine for use in preventing adenoviral gizzard erosion |
| 02/26/2015 | WO2015024669A1 Combination vaccine |
| 02/26/2015 | WO2015024668A2 Respiratory syncytial virus (rsv) vaccine |
| 02/26/2015 | WO2015024666A1 Composition and vaccine for treating lung cancer |
| 02/26/2015 | WO2015024665A1 Rabies vaccine |
| 02/26/2015 | WO2015024664A1 Composition and vaccine for treating prostate cancer |
| 02/26/2015 | WO2015024484A1 New rabies vaccine and method for preparation thereof |
| 02/26/2015 | WO2015024060A1 Immunoreceptor modulation for treating cancer and viral infections |
| 02/26/2015 | WO2015024042A1 Immunoreceptor modulation for treating cancer and viral infections |
| 02/26/2015 | WO2014006217A9 Dimeric protein with triple mutations |
| 02/26/2015 | US20150056254 Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same |
| 02/26/2015 | US20150056252 Composition and Method for Diagnosis and Immunotherapy of Lung Cancer |
| 02/26/2015 | US20150056250 Adjuvant Formulations and Methods |
| 02/26/2015 | US20150056249 Influenza vaccines |
| 02/26/2015 | US20150056248 Porcine circovirus type 2 (pcv2) subunit vaccine |
| 02/26/2015 | US20150056247 Sequential and repeated immunization with four or more vector-based HIV gene vaccines |
| 02/26/2015 | US20150056246 Subunit vaccine delivery platform for robust humoral and cellular immune responses |
| 02/26/2015 | US20150056245 Recombinant inactivated viral vector vaccine |
| 02/26/2015 | US20150056244 Antigens and Vaccines Directed Against Human Enteroviruses |
| 02/26/2015 | US20150056243 Multicomponent or monocomponent vaccine to be used against chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure |
| 02/26/2015 | US20150056242 Novel live recombinant booster vaccine against tuberculosis |
| 02/26/2015 | US20150056241 Compositions And Methods For Immunodominant Antigens |
| 02/26/2015 | US20150056240 Compositions and methods related to protein a (spa) variants |
| 02/26/2015 | US20150056239 Fused antigen vaccines and compositions against streptococcus pneumoniae |
| 02/26/2015 | US20150056238 Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof |
| 02/26/2015 | US20150056237 Method of altering the immundominance hierarchy of hiv gag by dna vaccine expressing conserved regions |
| 02/26/2015 | US20150056235 Materials and methods for respiratory disease control in canines |
| 02/26/2015 | US20150056234 Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines |
| 02/26/2015 | US20150056233 Influenza hemagglutinin proteins and methods of use thereof |
| 02/26/2015 | US20150056232 Recombinant bacterium for induction of cellular immune response |
| 02/26/2015 | US20150056231 Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines |
| 02/26/2015 | US20150056230 Equine Encephalitis Virus Vaccines and Methods of Using Thereof |
| 02/26/2015 | US20150056229 Dna sequence, and recombinant preparation of the grass pollen allergen lol p 4 |
| 02/26/2015 | US20150056227 Priming of an immune response |
| 02/26/2015 | US20150056226 Immunotherapeutic agent |
| 02/26/2015 | US20150056225 HLA Class II Deficient Cells, HLA Class I Deficient Cells Capable of Expressing HLA Class II Proteins, and Uses Thereof |
| 02/26/2015 | US20150056224 Compositions and methods for activating stimulator of interferon gene-dependent signalling |
| 02/26/2015 | US20150056223 Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease |
| 02/26/2015 | US20150056218 P97 fragments with transfer activity |
| 02/26/2015 | US20150056217 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4 associated disorders |
| 02/26/2015 | US20150056216 Antibody combinations and use of same for treating cancer |
| 02/26/2015 | US20150056209 Peptide mimotopes to oxidation specific epitopes |
| 02/26/2015 | US20150056207 Combination therapy with c-met and egfr antagonists |
| 02/26/2015 | US20150056204 Dr5 receptor agonist combinations |
| 02/26/2015 | US20150056197 Vaccines against hpv |
| 02/26/2015 | US20150056195 Compositions and methods for inihibiting tumorigenicity of senescent cancer cells induced by chemotherapy |
| 02/26/2015 | US20150056191 Igf1 biomarker for igf1r inhibitor therapy |
| 02/26/2015 | US20150056189 Cdr-modified anti-siglec-15 antibody |
| 02/26/2015 | US20150056186 Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent |
| 02/26/2015 | US20150056181 Nanocarriers with multi-photon response elements |
| 02/26/2015 | US20150056163 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/26/2015 | US20150056159 The IgM and IgE Heavy Chain Domain 2 as Covalently Linked Homodimerization Modules for the Generation of Fusion Proteins with Dual Specificity |
| 02/26/2015 | US20150056135 Treatment of Proliferative Disorders Using Antibodies to PSMA |
| 02/26/2015 | US20150056134 Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis A |
| 02/25/2015 | EP2840091A1 Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof |
| 02/25/2015 | EP2839843A1 VLA-1 antagonist for use in treating stroke |
| 02/25/2015 | EP2839842A1 Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof |
| 02/25/2015 | EP2839841A1 Fowl adenovirus vaccine |
| 02/25/2015 | EP2839840A1 Recombinant trivalent vaccine against human influenza |